Results 231 to 240 of about 1,453,138 (305)

Brainstem and Cerebellar Volume Loss and Associated Clinical Features in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Progressive Supranuclear Palsy (PSP) is a neurodegenerative ‘tauopathy’ with predominating pathology in the basal ganglia and midbrain. Caudal tau spread frequently implicates the cerebellum; however, the pattern of atrophy remains equivocal.
Chloe Spiegel, Timothy P. Siejka, Cassandra Marotta, Josh J. Y. Lee, Kelly Bertram, Terence J. O'Brien, Meng Law, Lucy Vivash, Ian H. Harding   +8 more
wiley   +1 more source

Systematic Literature Review of the Economic and Quality of Life Burden of Congenital and Immune-Mediated Thrombotic Thrombocytopenic Purpura. [PDF]

J Blood Med
Kaur H, Ghoshal D, Khurana IS.
europepmc   +1 more source

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Cost-effectiveness analysis of sugemalimab plus chemotherapy for the first-line treatment of advanced gastric cancer or gastroesophageal junction cancer. [PDF]

Hum Vaccin Immunother
Yan C, He J, Lv G, Gao Y, Li J, Diao R.
europepmc   +1 more source

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source

A harm-threshold model for ethical organ allocation. [PDF]

Front Health Serv
Lin YJ.
europepmc   +1 more source

Can telemedicine help integrate the referral-based healthcare system? An economic and operational analysis. [PDF]

PLoS One
Cao X, Li G, Zhao H.
europepmc   +1 more source

Validation of CURB-65, CRB-65, NEWS2, qSOFA, and 4C scores for predicting mortality in COVID-19 patients across seven emergency Departments in Colombia. [PDF]

Front Med (Lausanne)
Valderrama-Beltrán SL, Cuervo-Rojas J, Rondón M, Martinez-Vernaza S, De La Hoz Siegler IH, Rodriguez-Morales AJ, Cañas-Arboleda A, Muñoz O, Padilla M, Mesa-Rubio ML, Rojas JA, Bravo Ojeda JS, Villa J, Chacón Sarmiento JA, Patiño S, Tarud Ayub R, Aristizábal C, Rengifo P, Tambini G, Bertagnolio S, Diaz J, Reveiz L, Álvarez-Moreno C.   +22 more
europepmc   +1 more source

External validation, recalibration, and clinical utility of the kidney failure risk equation in patients with advanced CKD: a nationwide retrospective cohort analysis in Peru. [PDF]

BMC Nephrol
Bravo-Zúñiga JI, Soto-Becerra P, Coila-Paricahua EJ, Chávez-Gómez R, Pérez-Tejada E, Pardo-Villafranca AV, Arce-Gallo LC, Diaz-Obregón D.   +7 more
europepmc   +1 more source

Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer. [PDF]

Sci Rep
Chen HL, Chueh CH, Huang WM, Chan SH, Cheng HH, Chiang SC, Wu CE, Wen YW, Tsai YW.   +8 more
europepmc   +1 more source